MATRIX CAPITAL MANAGEMENT COMPANY, LP Adaptive Biotechnologies Corporation Transaction History

MATRIX CAPITAL MANAGEMENT COMPANY, LP portfolio value:

$82.39M
portfolio value

MATRIX CAPITAL MANAGEMENT COMPANY, LP quarter portfolio value change:

-11.99%
quarter

Adaptive Biotechnologies Corporation 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares -11.22M $7.12 11.57M
Q2 2022 share 0.00% 0 shares -67.00M $8.09 11.57M
Q1 2022 share 0.00% 0 shares -164.09M $13.88 11.57M
Q4 2021 share 0.00% 0 shares -68.62M $28.33 11.57M
Q3 2021 share Decrease -1.93% -227.5K shares -88.8M $33.99 11.57M
Q2 2021 share Decrease -4.14% -509K shares -13.41M $40.86 11.80M
Q1 2021 share Decrease -6.15% -806K shares -279.93M $40.26 12.30M
Q4 2020 share 0.00% 0 shares 137.70M $59.13 13.11M
Q3 2020 share Decrease -13.23% -2M shares -93.48M $48.63 13.11M
Q2 2020 share 0.00% 0 shares 311.37M $48.38 15.11M
Q1 2020 share Decrease -12.79% -2.21M shares -98.68M $27.78 15.11M
Q4 2019 share 0.00% 0 shares -16.98M $29.92 17.33M
Q3 2019 share 0.00% 0 shares -301.58M $30.9 17.33M
Q2 2019 share Increase 0.00% 17.33M shares 837.14M $48.3 17.33M